In 2019, we invested in Laboratoires Steripharma, a well-established pharmaceutical business in Morocco by acquiring a stake in the company from several minority shareholders. Steripharma was founded in 1999 and has since developed a large portfolio of drugs with strong recognition among patients and practitioners.
Steripharma has its own range of medicines (generics) and also produces/distributes drugs under license for leading international laboratories. Its product range covers major therapeutic areas, including infectiology and parasitology, cardiology, respiratory system, digestive system, dental care, ophthalmology and dermatology.